The Second Annual Joint Scientific Meeting of the Heart Valve Society of America & Society for Heart Valve Disease will be held in New York City from April 15 - 17. Valves in the Heart of the Big Apple VI: Evaluation & Management of Valvular Heart will provide state-of-the-art information about the latest strategies for diagnosis and treatment of this growing public health problem. Submissions are open for cases and abstracts for presentation during the session.
(PRWEB) November 23, 2009 -- Heart valve disease will be the focus of the Second Annual Joint Scientific Meeting of the world’s most prominent heart valve disease societies — the Heart Valve Society of America (HVSA) and Society for Heart Valve Disease (SHVD). The conference — Valves in the Heart of the Big Apple VI: Evaluation & Management of Valvular Heart Diseases 2010 will take place April 15-17, 2010 in New York City.
In addition to a series of state-of-the-art plenary lectures and mini-symposia, the conference is inviting physicians from around the world to submit their most challenging valvular heart disease case for the consideration for presentation during the event.
Case categories include:
In addition, the conference will provide the opportunity for authors to compete to present original research in oral or poster format.
Abstract categories include:
Cases and abstracts can be submitted through December 22, 2010.
In addition to HVSA and SHVD, the conference is co-sponsored by the New York Cardiological Society of the New York State Chapter/American College of Cardiology.
Valves in the Heart of the Big Apple VI: Evaluation & Management of Valvular Heart Disease 2010 has been approved for AMA PRA Category 1 Credit. CME credits will be provided by SUNY Downstate Medical Center, Office of Continuing Medical Education.
Valvular heart diseases are among the most prominent causes of heart failure and premature cardiac death. It is estimated that more than 15 million Americans have some type of heart valve abnormality, and in more than five million, the disease is moderate to severe. Three to four million will require surgery at some time in their lives.
Valve diseases increase in frequency as people grow older. With the aging of the Baby Boom generation, heart valve diseases are emerging as an important public health concern.
Valves in the Heart of the Big Apple VI: Evaluation and Management of Valvular Heart Diseases 2010 will provide state-of-the-art information for cardiologists, cardiothoracic surgeons, other physicians, researchers, allied health professionals, fellows and students from around the world.
The symposium will be conducted by nationally and internationally-recognized clinicians and researchers specializing in the field.
Course features include:
The program executive committee comprises:
Jeffrey S. Borer, M.D. (co-chair)
Professor and Chairman, Department of Medicine and Chief/Division of Cardiovascular Medicine
SUNY Downstate Medical Center
President, Heart Valve Society of America
Maurice E. Sarano, M.D. (co-chair)
Director, Valvular Heart Disease Clinic, Mayo Clinic
Executive Vice President, Heart Valve Society of America
Robert O. Bonow, MD
Goldberg Distinguished Professor of Medicine; Chief, Division of Cardiology, Northwestern University Medical School
President, Society of Heart Valve Disease; Vice President/Heart Valve Society of America
Friedrich W. Mohr, MD, PhD
Herzzentrum Universitaet Leipzig
Past President, Society of Heart Valve Disease
Cary W. Akins, MD
Clinical Professor of Surgery, Harvard Medical School; Division of Cardiac Surgery, Massachusetts General Hospital
Vice President/Heart Valve Society of America
O. Wayne Isom, MD
Terry Allen Kramer Professor and Chairman, Department of Cardiothoracic Surgery, Weill Medical College of Cornell University
Vice President, Heart Valve Society of America
The Heart Valve Society of America was founded to advance recognition and knowledge of the field. Its mission is to promote research, educate medical professionals about the evaluation and treatment of heart valve disease, serve as an informational resource for government, private industry, health care providers, the media and public, and encourage and facilitate education of future heart valve disease specialists.
The Society of Heart Valve Disease has as its objective to undertake, promote, support and encourage research and educate the public in the causes, prevention and treatment of heart valve disease. Its mission is to advance the practice, science and art of treating heart valve disease, through a multi-disciplinary approach with the ultimate aim of reducing the global burden of the disease.
# # #
